Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ad5 EBOV DNA vaccine - Academy of Military Medical Sciences/Tianjin CanSino

Next Previous
Search
Drug Profile

Ad5 EBOV DNA vaccine - Academy of Military Medical Sciences/Tianjin CanSino

Alternative Names: Ad5 vector based Ebola vaccine - Academy of Military Medical Sciences/Tianjin CanSino; Ad5-EBOV; Ebola adenovirus vector vaccine - Academy of Military Medical Sciences/Tianjin CanSino; Ebola adenovirus vector vaccine - Tianjin CanSino/Academy of Military Medical Sciences; Ebola Zaire vaccine - Academy of Military Medical Sciences/Tianjin CanSino; Ebola Zaire vaccine - Tianjin CanSino/Academy of Military Medical Sciences

Latest Information Update: 01 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Academy of Military Medical Sciences; Tianjin CanSino Biotechnology
  • Developer Academy of Military Medical Sciences; Beijing Institute of Biotechnology; Jiangsu Provincial Center for Disease Control and Prevention; Tianjin CanSino Biotechnology; Zhejiang University
  • Class DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Ebola virus infections

Most Recent Events

  • 01 Oct 2021 No development reported - Phase-II for Ebola virus infections (Prevention, In volunteers) in Sierra Leone (IM)
  • 20 Oct 2017 Registered for Ebola virus infections (Prevention) in China (IM)
  • 01 Jul 2016 Jiangsu Province Centers for Disease Control and Prevention completes a phase-II trial in Ebola virus infections (Prevention) in Sierra Leone (IM) (NCT02575456)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top